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ABSTRACT Bioﬁlm infections exhibit high tolerance against antibiotic treatment.
The study of bioﬁlms is complicated by phenotypic heterogeneity; bioﬁlm subpopu-
lations differ in their metabolic activities and their responses to antibiotics. Here, we
describe the use of the bio-orthogonal noncanonical amino acid tagging (BONCAT)
method to enable selective proteomic analysis of a Pseudomonas aeruginosa bioﬁlm
subpopulation. Through controlled expression of a mutant methionyl-tRNA synthe-
tase, we targeted BONCAT labeling to cells in the regions of bioﬁlm microcolonies
that showed increased tolerance to antibiotics. We enriched and identiﬁed proteins
synthesized by cells in these regions. Compared to the entire bioﬁlm proteome, the
labeled subpopulation was characterized by a lower abundance of ribosomal pro-
teins and was enriched in proteins of unknown function. We performed a pulse-
labeling experiment to determine the dynamic proteomic response of the tolerant
subpopulation to supra-MIC treatment with the ﬂuoroquinolone antibiotic cipro-
ﬂoxacin. The adaptive response included the upregulation of proteins required for
sensing and repairing DNA damage and substantial changes in the expression of en-
zymes involved in central carbon metabolism. We differentiated the immediate pro-
teomic response, characterized by an increase in ﬂagellar motility, from the long-
term adaptive strategy, which included the upregulation of purine synthesis. This
targeted, selective analysis of a bacterial subpopulation demonstrates how the study
of proteome dynamics can enhance our understanding of bioﬁlm heterogeneity and
antibiotic tolerance.
IMPORTANCE Bacterial growth is frequently characterized by behavioral heteroge-
neity at the single-cell level. Heterogeneity is especially evident in the physiology of
bioﬁlms, in which distinct cellular subpopulations can respond differently to stresses,
including subpopulations of pathogenic bioﬁlms that are more tolerant to antibiot-
ics. Global proteomic analysis affords insights into cellular physiology but cannot
identify proteins expressed in a particular subpopulation of interest. Here, we report
a chemical biology method to selectively label, enrich, and identify proteins ex-
pressed by cells within distinct regions of bioﬁlm microcolonies. We used this ap-
proach to study changes in protein synthesis by the subpopulation of antibiotic-
tolerant cells throughout a course of treatment. We found substantial differences
between the initial response and the long-term adaptive strategy that bioﬁlm cells
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use to cope with antibiotic stress. The method we describe is readily applicable to
investigations of bacterial heterogeneity in diverse contexts.
KEYWORDS BONCAT, Pseudomonas aeruginosa, antibiotic resistance, bioﬁlms,
proteomics
Compared to their planktonic counterparts, bacteria living in surface-associatedbioﬁlms are more tolerant to a variety of stresses (1). Of clinical importance is the
increased antibiotic tolerance of bioﬁlms, which impedes elimination of chronic infec-
tions. Phenotypic tolerance is distinct from genotypic resistance, though the evolution
of resistance can be promoted by the persistence of cells following treatment (2). The
opportunistic pathogen Pseudomonas aeruginosa serves as a model organism for study
of both bioﬁlm physiology and antibiotic-tolerant infections. P. aeruginosa is a primary
contributor to chronic infections of the cystic ﬁbrosis lung, where it forms bioﬁlms that
are recalcitrant to the host immune system and antimicrobial therapies. Antibiotic
tolerance by these bioﬁlm infections has been documented within the host (3) and
through in vitro bioﬁlm studies (4).
Research on P. aeruginosa bioﬁlms grown in vitro has revealed the importance of
spatial heterogeneity in their response to antibiotics; speciﬁc subpopulations survive
treatment while others do not (1, 5). For example, drug classes such as ﬂuoroquinolones
(6), aminoglycosides (7), and -lactams (8), which target active processes (DNA repli-
cation, translation, and peptidoglycan synthesis, respectively) kill growing cells within
the bioﬁlm regions that have greater access to exogenous nutrients. Explanations for
the spatial segregation of these antibiotic responses include reduced penetration of
small-molecule antibiotics, decreased metabolic rates, and altered metabolism (1, 5).
Conversely, polymyxins and detergents, which disrupt cellular membranes, preferen-
tially kill dormant cells in the interiors of bioﬁlm microstructures (6).
Measurements of mRNA or protein abundance can offer comprehensive and unbi-
ased views of a physiological response to antibiotics (9–11), but experimental chal-
lenges limit the investigation of tolerant bioﬁlm subpopulations. Because only a subset
of cells exhibit tolerance, any analysis must distinguish tolerant cells from those that do
not survive treatment. Laser capture microdissection has been used to isolate bioﬁlm
cells from spatially distinct regions of bioﬁlms, and quantitative PCR (qPCR) and DNA
microarray analyses have been used to quantify differences in mRNA transcript abun-
dances between these regions (12, 13). This approach has been applied to the explo-
ration of bioﬁlm heterogeneity in general, but not to the study of subpopulation-
speciﬁc responses to antibiotics. Global proteomic measurements have been widely
used to better understand bioﬁlm physiology (14), but targeted selective approaches
have been limited.
An important recent advance has been the application of pulsed stable isotope
labeling with amino acids in cell culture (pSILAC) to quantify changes in protein
expression following adaptation of bioﬁlm cells to challenge with antibiotics (15). Via
pulsed addition of an amino acid isotopolog, pSILAC can provide a means to distin-
guish, based on mass, proteins synthesized before and during the pulse (16). Chua et
al. characterized the long-term proteomic response of tolerant cells by treating bioﬁlms
with the clinical polymyxin colistin for 8 h to allow nontolerant cells to die and then
labeling newly synthesized proteins with an extended (48-h) amino acid isotopolog
pulse. This approach ensured that labeled and identiﬁed proteins were synthesized
over the 2-day period by the tolerant subpopulation of interest. The results of this study
revealed the importance of type IV-mediated motility in the resistance of P. aeruginosa
bioﬁlms to colistin.
To address the challenges posed by dynamic and heterogeneous responses, we
employed the bio-orthogonal noncanonical amino acid tagging (BONCAT) method for
selective proteomic analysis (17, 18). BONCAT relies on the incorporation into cellular
proteins of a noncanonical amino acid (ncAA) that bears a bio-orthogonal chemical
handle. Following incorporation, labeled proteins can be conjugated to an afﬁnity tag
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and enriched from the pool of unlabeled proteins. Enriched proteins can be identiﬁed
and quantiﬁed via liquid chromatography-tandem mass spectrometry (LC-MS/MS). Like
pSILAC, BONCAT provides temporal selectivity; proteins synthesized during the ncAA
pulse are chemically distinct from preexisting proteins. However, a key advantage of
this enrichment-based method is that labeled proteins can be physically separated
from the rest of the proteome. MS-based protein identiﬁcation is sensitive to the
complexity of the sample, such that proteins of low abundance often go unidentiﬁed;
therefore, reducing sample complexity can aid in the detection of proteins of interest.
We and others have shown the exquisite temporal sensitivity of BONCAT-based en-
richment in the context of dynamic proteome changes (19, 20). In bacteria, ncAA pulse
times as short as a few minutes have been used to quantify dynamic processes in Vibrio
harveyi (21, 22), Escherichia coli (23), and Bacillus subtilis (24), while extended pulse
times have been used to identify proteins synthesized at extremely low rates under
conditions of anaerobic survival in P. aeruginosa (25).
BONCAT labeling can target cellular subpopulations through the use of an ncAA that
is not incorporated into proteins by the endogenous translational machinery. Cells
expressing a mutant aminoacyl-tRNA synthetase (mRS) that has been engineered to
charge the ncAA to a cognate tRNA are labeled. Such noncanonical synthetases have
been developed for the methionine surrogates azidonorleucine (26) and 2-aminooctynoic
acid (27) and for the phenylalanine surrogate azidophenylalanine (28). By restricting
expression of the mRS to the cell type of interest, protein labeling can focus on a
subpopulation of cells within a complex heterogeneous system. Cell targeting can be
accomplished by genetically restricting the mRS gene to a species of interest (e.g.,
bacteria in the presence of host cells [27, 29]) or by placing mRS expression under
control of a cell-state-speciﬁc promoter (e.g., under reactive oxygen stress conditions
for E. coli [30]).
Here, we describe an adaptation of the BONCAT method for cell- and time-resolved
analysis of protein synthesis in heterogeneous bacterial bioﬁlms. We direct cell-
selective labeling of proteins with the ncAA azidonorleucine (Anl) (see Fig. S1 in the
supplemental material) through controlled expression of a mutant form of the E. coli
methionyl-tRNA synthetase (designated NLL-MetRS [26]). By controlling expression of
NLL-MetRS with the promoter element for the stationary-phase sigma factor rpoS, we
restricted protein labeling to the inner P. aeruginosa bioﬁlm subpopulation. We used
this approach to selectively analyze the dynamic proteomic response of bioﬁlm cells
that are tolerant to ciproﬂoxacin.
(Parts of this work were conducted as B. M. Babin’s thesis project and are presented
in chapter 4 of his dissertation [31].)
RESULTS
The rpoS promoter enables cell-state-selective labeling. To selectively target
antibiotic-tolerant bioﬁlm cells, we aimed to restrict BONCAT labeling by placing
NLL-MetRS expression under control of an endogenous, cell-state-selective promoter.
Because bioﬁlm regions more tolerant to many antibiotics contain cells with decreased
metabolic rates, we reasoned that the use of a promoter whose activity increases
during planktonic stationary phase, when metabolic rates are similarly decreased,
would provide the desired selectivity. Cellular levels of the alternative sigma factor 38
are upregulated in response to a variety of stresses. In P. aeruginosa and other bacteria,
38, which is encoded by the gene rpoS, is upregulated during the transition from
exponential to stationary phase during planktonic growth (32); we hypothesized that
the rpoS promoter would enable selective protein labeling.
We ﬁrst evaluated the activity of the rpoS promoter in planktonic cells. We placed
the 1-kb region upstream of the endogenous rpoS gene 5= to gfp and transposed this
expression cassette to the Tn7 locus in P. aeruginosa PA14 to generate PrpoS:gfp
(Fig. 1A). Fluorescence imaging of PrpoS:gfp throughout growth from early exponential
phase (150 min following dilution) to late stationary phase (overnight) in LB medium
revealed the expected increase of promoter activity in high-cell-density, nutrient-
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depleted cultures (Fig. 1B). We observed cellular heterogeneity in the expression of
green ﬂuorescent protein (GFP). At the early time point, only a small subpopulation of
cells was GFP positive. The GFP-positive fraction increased in early stationary phase, and
after overnight growth essentially all cells expressed GFP. In contrast, wild-type cells
exhibited no ﬂuorescence (Fig. S2A), and when GFP expression was placed under
control of the strong, constitutive trc promoter (33), all cells were GFP positive at all
time points (Fig. S2B).
Encouraged by these results, we generated a strain in which expression of NLL-
MetRS was controlled by the rpoS promoter, again transposed to the Tn7 locus. The
protein was outﬁtted with an N-terminal six-histidine tag to allow for Western blotting
detection and a C-terminal translational fusion to mCherry, yielding PrpoS:nll-mc (Fig. 1A).
We ﬁrst veriﬁed that this strain allows for Anl labeling under planktonic growth
conditions. We grew this strain from early exponential phase to stationary phase in FAB
minimal medium and treated samples of the culture with Anl for 15 min at three points
throughout growth (Fig. 1C). To provide a positive control, we transformed strain PA14
with a plasmid that enables expression of NLL-MetRS under control of the Para
arabinose-inducible promoter and treated the transformed cells with arabinose and Anl
during exponential phase (Fig. S2C). Consistent with our GFP measurements, Western
blotting showed growth phase-dependent expression of NLL-MetRS under control of
the rpoS promoter (Fig. 1D). To detect Anl incorporation, we took advantage of the
selective azide-alkyne cycloaddition (the “click” reaction). We treated cell lysates with
alkyne-carboxytetramethylrhodamine (alkyne-TAMRA) (Fig. S1) under copper-catalyzed
click conditions, separated proteins via SDS-PAGE, and imaged ﬂuorescence. In early
exponential phase, when NLL-MetRS was not present, labeling was not detected.
FIG 1 Cell-state-selective labeling using the rpoS promoter. (A) P. aeruginosa was engineered to express GFP or an
NLL-MetRS–mCherry translational fusion under control of the endogenous rpoS promoter. Expression cassettes were
transposed to the Tn7 chromosomal locus. (B) Representative images of GFP ﬂuorescence of the PrpoS:gfp strain throughout
growth in LB medium. GFP ﬂuorescence (top) and a GFP–bright-ﬁeld merge (bottom) are shown. The arrow indicates a
GFP-positive cell at the early time point. The times after 1:200 dilution into fresh medium are indicated above the panels.
(C) Optical density at 500 nm of PrpoS:nll-mc cells grown in liquid culture in minimal FAB medium. At each indicated time
point, an aliquot was removed and incubated with 1 mM Anl for 15 min. (D) Lysates were treated with alkyne-TAMRA and
separated via SDS-PAGE to visualize Anl incorporation. Coomassie staining of the same gel indicates equal protein loading.
Lysates were probed by Western blotting for the six-histidine tag on NLL-MetRS.
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Labeling was strongest in early stationary phase, when NLL-MetRS expression was
moderate, and low but detectable in stationary phase. For all conditions, Coomassie
staining was used to verify equal protein loading. The rate of Anl incorporation was
dependent on both the abundance of NLL-MetRS and the overall rate of protein
synthesis during the 15-min Anl pulse, so we interpreted the lower levels of Anl labeling
in stationary phase as a reﬂection of the decreased rates of protein synthesis in this
state.
Labeling and proteomic analysis of a bioﬁlm subpopulation. To test for sub-
population targeting in bioﬁlms, we cultured bioﬁlms on glass surfaces under constant
medium ﬂow in ﬂow cells. Four-day-old live bioﬁlms were analyzed via confocal
microscopy. SYTO 9 was used as a cell stain, and mCherry ﬂuorescence was used to
locate cells expressing the NLL-MetRS–mCherry fusion (Fig. 2A). PrpoS:nll-mc exhibited
mCherry ﬂuorescence only in the lower parts of bioﬁlm structures, while a strain
expressing NLL-MetRS from a strong constitutive promoter (Ptrc:nll-mc) exhibited
mCherry ﬂuorescence throughout the bioﬁlm structures. Because only cells that express
NLL-MetRS can incorporate Anl, we expected that the difference in expression patterns
would allow for subpopulation-speciﬁc BONCAT labeling.
To visualize BONCAT labeling, we again cultured bioﬁlms in ﬂow cells for 4 days and
then treated them with Anl for 1.5 h. Anl incorporation was visualized by treating ﬁxed
bioﬁlms with aza-dibenzocyclooctyne (DBCO)-TAMRA (Fig. S1). The strained alkyne
structure present in DBCO allows for copper-free azide-alkyne cycloaddition and re-
moves the requirement for diffusion of the ligand, copper catalyst, and reductant
FIG 2 Targeted proteomic analysis of a bioﬁlm subpopulation. (A) Detection of mCherry ﬂuorescence (green) in live bioﬁlms was used to locate cells expressing
the NLL-MetRS–mCherry fusion. Bioﬁlms were counterstained with SYTO9 (magenta) immediately before imaging. (B) Following Anl treatment, BONCAT labeling
in bioﬁlms was visualized by treating ﬁxed bioﬁlms with DBCO-TAMRA (green). Bioﬁlms were counterstained with SYTO9 (magenta). Colocalization of
ﬂuorescent signals is displayed in white. For panels A and B, cross-sections were reconstructed from confocal image stacks. (C) Proteins identiﬁed following
BONCAT enrichment from PrpoS:nll-mc and Ptrc:nll-mc strains. (D) Quantiﬁcation of relative protein abundances following enrichment from both strains.
Ribosomal proteins are shown in orange. Proteins discussed in the text are indicated by gene name. The complete set of LFQ values, ratios, and adjusted
P values is provided in Data Set S1. (E) Spatial distribution of GFP expression (green) under control of the rpoS or algP promoters in live bioﬁlms. Bioﬁlms were
counterstained with SYTO62 (magenta).
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needed for conjugation of alkyne-TAMRA. Cells were counterstained with SYTO 9
(Fig. 2B). As expected, we observed similar patterns in Anl labeling as for NLL-MetRS
expression. PrpoS:nll-mc incorporated Anl predominantly in the lower parts of bioﬁlm
structures, and Ptrc:nll-mc incorporated Anl throughout the entirety of the bioﬁlm.
Wild-type cells exhibited minimal background ﬂuorescence, likely due to nonspeciﬁc
interactions between DBCO-TAMRA and the cells.
To evaluate our ability to detect proteins preferentially expressed by the labeled
subpopulation, we compared proteomes enriched from Ptrc:nll-mc and PrpoS:nll-mc
strains. To obtain adequate protein yields, bioﬁlms of each strain were grown for 4 days
in silicone rubber tubing and treated with Anl for 1.5 h before cells were collected and
lysed. We veriﬁed Anl incorporation by treating cell lysates with alkyne-TAMRA and
analyzing TAMRA ﬂuorescence via SDS-PAGE (Fig. S3A). We observed a statistically
signiﬁcant increase in ﬂuorescence for Ptrc:nll-mc and PrpoS:nll-mc samples compared to
a methionine-treated control (P  0.01 for all) (Fig. S3B). To enable enrichment of
Anl-labeled proteins, we treated lysates with DBCO–sulfo-biotin (Fig. S1). Western blot
detection using streptavidin revealed substantial biotinylation of Anl-labeled proteins
and three bands in the methionine-treated control, likely corresponding to endoge-
nously biotinylated proteins (Fig. S3C). Three of four Anl-treated samples showed a
signiﬁcant increase in biotinylation (P  0.05) (Fig. S3D).
Anl-labeled proteins were enriched on streptavidin beads and analyzed via LC-MS/
MS. We detected 908 proteins among two replicates from each strain, with fewer
identiﬁcations from the PrpoS:nll-mc strain (726 [80%]) (Fig. 2C). Based on in-gel ﬂuo-
rescence and Western blot detection (Fig. S3A to D), Anl incorporation was not lower
in these samples, so the decreased number of identiﬁed proteins from the PrpoS:nll-mc
samples was likely due to the targeted analysis of a subset of bioﬁlm cells. We
quantiﬁed relative abundances of proteins identiﬁed from both strains via label-free
quantiﬁcation (LFQ) and found the abundance levels of 15 and 24 proteins to be at least
2-fold increased or decreased in the PrpoS:nll-mc strain, respectively (Fig. 2D; Tables S1
and S2). Full proteomic results from this experiment are provided in Data Set S1.
We hypothesized that the subpopulation labeled in the PrpoS:nll-mc strain would
exhibit decreased metabolic rates. We looked for differences in ribosome synthesis and
found that ribosomal proteins were signiﬁcantly less abundant in samples enriched
from the PrpoS:nll-mc strain (P  0.05). The median relative abundance of 36 quantiﬁed
ribosomal proteins was 1.7-fold lower in PrpoS:nll-mc samples than in the Ptrc:nll-mc
samples (Fig. S3E). Furthermore, the protein with the lowest relative abundance in the
PrpoS:nll-mc samples was the nonessential ribosomal protein RpmC (protein L29 of the
60S subunit; 22-fold less abundant). These results are consistent with measurements
showing greater translational activity in the upper regions of ﬂow cell bioﬁlms (34) and
the higher levels of transcripts for ribosomal components found in highly metabolically
active versus less-active cells within colony bioﬁlms (13).
Proteins with known functions found to be enriched in the PrpoS:nll-mc samples
included those involved in antibiotic resistance, stress protection, and alginate regu-
lation (Fig. 2D). The lytic transglycosylase MltF (accession number PA14_15720), was the
protein most enriched in the PrpoS:nll-mc subpopulation. MltF and other transglycosy-
lases involved in peptidoglycan remodeling have been implicated in resistance to the
-lactams piperacillin, cefotaxime, and ceftazidime, though there are conﬂicting reports
on the effects of mltF disruption on MICs (35,36). Bioﬁlm resistance to -lactams has
been linked previously to upregulation of the -lactamase AmpC in peripheral cells in
response to antibiotic treatment (8). The identiﬁcation of MltF upregulation in the
absence of antibiotic stimulation and within the bioﬁlm interior supports a comple-
mentary approach to tolerance in which cells are preemptively prepared for antibiotic
stress.
We found the starvation factor Dps to be signiﬁcantly more abundant in the
PrpoS:nll-mc enrichment experiment. Dps is a global DNA remodeling protein that
confers protection against a variety of stresses, including nutrient limitation, oxidative
stress, UV irradiation, and others (37,38). In E. coli, dps transcription is RpoS dependent,
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and Dps is among the most abundant proteins in stationary-phase cells (39). The higher
abundance of Dps in the bioﬁlm interior is consistent with the expected nutrient
deprivation of cells in this region.
We also observed the DNA binding protein AlgP to be signiﬁcantly more abundant
in the PrpoS:nll-mc enrichment. AlgP is a regulator reported to be involved in the mucoid
phenotype and in the synthesis of the exopolysaccharide alginate (40), though its
regulatory role may be more general. AlgP contains a histone-like domain, and immu-
nostaining combined with electron microscopy has revealed association of AlgP with
nucleoid ﬁbril structures (41), a ﬁnding reminiscent of other histone-like bacterial
proteins that play roles in nucleoid architecture and global regulation (42). Because
AlgP has not been reported to be speciﬁcally expressed in bioﬁlms or in slow-growing
cells, we chose this protein to validate the ability of our targeted proteomics approach
to provide information about region-speciﬁc protein expression. We grew bioﬁlms from
a strain that expresses GFP under control of the algP promoter (PalgP:gfp). After 4 days
of growth, GFP ﬂuorescence in PalgP:gfp bioﬁlms was visualized via confocal microscopy.
As predicted by our proteomic measurements, expression from the algP promoter was
restricted to cells within the bioﬁlm interior (Fig. 2E). This pattern of expression
matched the localization of GFP ﬂuorescence in PrpoS:gfp bioﬁlms (Fig. 2E) and the
localization of NLL-MetRS–mCherry expression (Fig. 2A) and Anl labeling (Fig. 2B)
observed in PrpoS:nll-mc bioﬁlms.
As a caveat, we note that the RpoS protein itself was equally abundant in the
PrpoS:nll-mc and Ptrc:nll-mc samples. The design of the expression cassette in PrpoS:nll-mc
places NLL-MetRS under transcriptional control of any regulatory regions that lie 1 kb
upstream of the endogenous rpoS gene. However, much of the control of RpoS protein
levels is known to be posttranscriptional, depending on the action of sRNAs, modiﬁed
translation rates, and tuned degradation (43). Additionally, NLL-MetRS was fused to
mCherry, which may increase its intracellular stability and further disconnect levels of
the mutant synthetase from levels of RpoS itself. We conclude that PrpoS:nll-mc cells
with high NLL-MetRS abundance are not necessarily cells with high RpoS abundance.
However, our imaging results from planktonic and bioﬁlm growth states showed that
the PrpoS:nll-mc strain can be used to target proteomic analysis to the cellular subpop-
ulation of interest.
BONCAT enrichment of proteins synthesized during ciproﬂoxacin treatment.
To identify the subpopulation-speciﬁc response to ciproﬂoxacin, we designed an
experiment to capture dynamic changes in the proteome throughout the course of
antibiotic challenge. A previous study using ﬂuorescent imaging of bioﬁlms treated
with ciproﬂoxacin showed a progression of cell death over the course of 13 h (6). Cell
death, visualized by propidium iodide staining, began between 4 and 9 h of treatment
and was restricted to peripheral regions of bioﬁlm microstructures. Protein synthesis,
measured by expression of an unstable GFP variant, continued in interior bioﬁlm
populations even after 13 h of treatment. We sought to investigate the set of proteins
made by bioﬁlm cells surviving in the presence of ciproﬂoxacin. We replicated this time
course of antibiotic challenge by treating 4-day-old PrpoS:nll-mc bioﬁlms with 60 g/ml
ciproﬂoxacin. To achieve temporal selectivity, we pulse-labeled bioﬁlms with Anl at 0,
4, or 13 h after ciproﬂoxacin was added. Each pulse was for 1.5 h to distinguish proteins
synthesized during this short pulse from the preexisting proteome. To serve as a
no-ciproﬂoxacin control, we also labeled untreated bioﬁlms for 1.5 h with Anl (Fig. 3A).
Given the evidence that the PrpoS:nll-mc strain targets labeling to cells in the bioﬁlm
regions known to tolerate ciproﬂoxacin, we expected that the majority of cells incor-
porating Anl would remain alive throughout treatment. We tracked the number of
viable cells recovered from bioﬁlms throughout the time course of treatment and found
two stages of killing (Fig. 3B). Compared to untreated bioﬁlms, those treated for 1.5 or
5.5 h both exhibited an approximately 50-fold loss in viable cells, while those treated
for 14.5 h exhibited an approximately 450-fold loss. Treatment with Anl had no effect
on the number of viable cells in untreated bioﬁlms (P 0.38, Welch’s t test). To quantify
Anl incorporation in ciproﬂoxacin-treated bioﬁlms, we treated lysates with alkyne-
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TAMRA and analyzed ﬂuorescence via SDS-PAGE (Fig. 3C and D). Strikingly, total Anl
incorporation decreased less than 2-fold throughout the course of ciproﬂoxacin treat-
ment. Even after 14.5 h of treatment, when only 0.2% of bioﬁlm cells remained viable,
the level of Anl incorporation by surviving cells (as measured by the ratio of TAMRA
ﬂuorescence to Coomassie staining in protein gels) was similar to that observed for
untreated cells. In this type of experiment, total Anl incorporation depends on the
number of cells expressing NLL-MetRS and the relative rates of protein synthesis and
protein degradation in these cells during each 1.5-h Anl pulse. We note that in-gel
ﬂuorescence measurements of Anl incorporation cannot distinguish these contributing
factors. Together, these results implied that while a majority (99.8%) of bioﬁlm cells
died over 14.5 h, the number of cells susceptible to Anl labeling remained nearly
constant during this period.
We performed BONCAT enrichment on lysates from each experimental condition
(performed in triplicate) and identiﬁed proteins by using LC-MS/MS. We identiﬁed more
than 1,200 proteins among all runs. Protein abundances, estimated by LFQ, were well
correlated among replicates for each time point (Fig. 3E). We used principal component
(PC) analysis to visualize the variance among replicates and experimental conditions
(Fig. 3F) and found that biological replicates clustered with one another and that
FIG 3 BONCAT analysis of protein synthesis during ciproﬂoxacin treatment. (A) Experimental timeline of bioﬁlm treatment and
proteome labeling. Bioﬁlms were grown in silicone rubber tubing for 4 days and then treated with 60 g/ml ciproﬂoxacin
(gray). Control bioﬁlms were untreated. For each condition, bioﬁlms were treated with Anl at the designated time point for
1.5 h (cross-hatched portion), harvested, and lysed. (B) Survival of bioﬁlm cells following exposure to ciproﬂoxacin for the
indicated treatment time and to 1 mM Anl as indicated. (C) Visualization of Anl incorporation in lysates treated with
alkyne-TAMRA. Coomassie staining was used to verify equal protein loading. (D) Anl incorporation was quantiﬁed by dividing
the TAMRA ﬂuorescence by the Coomassie intensity for four gel regions (means  standard deviations; n  4). Welch’s t-test
results are indicated: *, P  0.05; **, P  0.01. (E) Spearman rank correlation coefﬁcients for protein LFQ values, calculated
among all MS runs. (F) The top two principal component weights for each MS run. The percent variance explained by each
component is shown in parentheses. (G) Overlap of signiﬁcantly changed or uniquely identiﬁed proteins (down- and
upregulated proteins) at each time point throughout ciproﬂoxacin treatment.
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ciproﬂoxacin-treated samples were separated from the untreated control samples. For
each time point, we compared protein LFQ values in the treated samples and the
no-ciproﬂoxacin control, which yielded ratios for each protein that represented its
relative abundance (e.g., up- or downregulation) in treated and untreated samples.
Consistent with the correlation analysis, fewer proteins were signiﬁcantly changed
under the 1.5-h treatment condition (73 proteins) than under the 5.5-h treatment (187
proteins) or 14.5-h treatment (204 proteins) (Fig. 3G). Correlation, PC, and relative
abundance analysis results were consistent with the classiﬁcation of the proteomic data
into two subgroups: (i) a smaller group of proteins whose synthesis changed immedi-
ately upon ciproﬂoxacin exposure, and (ii) a larger group of late response proteins,
many of which were shared between the 5.5-h and 14.5-h groups.
For subsequent analyses, we divided proteins identiﬁed at each time point into
subsets of groups signiﬁcantly more or less abundant in the treated versus untreated
samples. Each group included proteins whose relative abundances were quantiﬁed
(fold change of 2 and false-discovery rate [FDR] adjusted P value of 0.05), as well as
proteins identiﬁed under one condition (i.e., found in at least two of three replicates)
but not identiﬁed under the other (i.e., not found in any replicates). Full proteomic
results are listed in Data Set S2.
The dynamic proteomic response to ciproﬂoxacin. Based on total Anl incorpo-
ration, protein translation rates were reduced in the 5.5- and 14.5-h samples. To test
whether this decrease could be explained by changes in ribosome expression, we
examined the relative abundance of ribosomal proteins at each time point compared
to those for the no-ciproﬂoxacin control (Fig. 4A). Ribosomal protein abundances were
essentially unchanged after 1.5 h of treatment but decreased more than 1.5-fold after
5.5 and 14.5 h of treatment. Interestingly, the nonessential ribosomal protein RpmJ (L36
of the 50S subunit) was substantially upregulated at each of the later time points. We
also found a signiﬁcant decrease in the cell division protein FtsZ under all ciproﬂoxacin-
treated conditions (Fig. 4B). Together, these ﬁndings suggest that translation rates and
cell division decrease upon ciproﬂoxacin exposure.
We next compared our results to known responses of P. aeruginosa to ciproﬂoxacin.
The responses of planktonic P. aeruginosa to sub-MIC and supra-MIC ciproﬂoxacin
treatments (0.01 to 1 g/ml) have been characterized via microarray and RNA sequenc-
FIG 4 Dynamic cellular responses to ciproﬂoxacin. (A) Box plots showing the distribution of ribosomal protein abundances for treated samples compared to
the untreated control. Each box indicates the second and third quartiles, and whiskers indicate the rest of the distribution. Values exceeding 1.5 times the
interquartile range are displayed as points. The nonessential ribosomal protein RpmJ is indicated. (B) Abundance of FtsZ in each sample (mean  standard
deviation; n  3; FDR adjusted P values are designated: *, P  0.05; ***, P  0.001). (C to F) Heat maps indicating the median abundance ratio for each time
point compared to the untreated control for proteins involved in DNA damage sensing and repair (C), ﬂagellum synthesis (D), purine metabolism (E), and central
carbon metabolism (F). *, P  0.05 (FDR-adjusted P value). The color scale for abundance ratios is shown under panel C. Gray boxes indicate time points for
which that protein was not quantitated. Hatched orange boxes indicate proteins that were identiﬁed for that time point (in at least two replicates) but absent
from the untreated control. An example of raw abundance measurements for panel C is given in Fig. S4. The complete set of LFQ values, ratios, and adjusted
P values is provided in Data Set S2.
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ing measurements of transcript abundances (10, 44–46). While the designs of these
experiments differed, we found two genes identiﬁed in all studies that showed con-
sistent responses to ciproﬂoxacin. This core response comprises genes involved in the
SOS response: LexA and RecA. Ciproﬂoxacin inhibits DNA gyrase activity, causing DNA
damage during replication attempts. DNA damage leads to an induction of the SOS
response, characterized by depletion of the SOS repressor LexA and the consequent
upregulation of genes that alleviate DNA damage stress (47). We did not identify LexA
in any experiments, but we detected upregulation of the LexA target RecA, which binds
to DNA lesions. Of the proteins involved in DNA damage response and repair found in
our data, all were either signiﬁcantly upregulated or uniquely identiﬁed for at least one
time point (Fig. 4C; Fig. S4). This set includes both subunits of DNA gyrase (GyrA and
GyrB), the direct target of ciproﬂoxacin, and proteins involved in sensing (RecA and
UvrA) and repairing (RecB, RecQ, and MutM) various types of DNA damage. The
identiﬁcation of these proteomic changes validated the experimental approach and
suggests that our results represent bona ﬁde physiological responses to ciproﬂoxacin.
As described above, early and late responses to ciproﬂoxacin differed in our data set.
In fact, only three proteins were signiﬁcantly upregulated at all time points: GyrB, the
protein chaperone HscK, and the methylisocitrate lyase PrpB. These proteins typify
functional categories of proteins we found to be upregulated by ciproﬂoxacin chal-
lenge, namely, those involved in remediating DNA damage and other stresses and
proteins involved in central metabolism. The differences between early and late
responses are best exempliﬁed by the contrasting behavior of proteins involved in
ﬂagellar synthesis and purine metabolism. Protein components of ﬂagella and ﬂagellar
regulation were signiﬁcantly upregulated at the early and middle time points of
ciproﬂoxacin treatment, including the immediate upregulation of FliC, FliM, and FlgM
(Fig. 4D). In contrast, many proteins involved in purine metabolism were upregulated
only at the 4.5- and 14.5-h time points (Fig. 4E). Of the proteins in the pathway for de
novo synthesis of IMP that we identiﬁed (PurBDEFHLMT), four of eight were signiﬁcantly
upregulated in at least one of the later time points. PurA, required for conversion of IMP
to AMP, was likewise upregulated. The ribonucleotide reductase complex (NrdA and
NrdB) that generates deoxyribonucleotides from their ribonucleotide precursors was
also upregulated.
Finally, some of the largest changes we observed were the up- or downregulation
of proteins involved in central metabolism, particularly components of the citrate
(tricarboxylic acid [TCA]) cycle (Fig. 4F). Of particular interest was the differential
behavior of the aconitases and isocitrate dehydrogenases (ICDs). The P. aeruginosa
genome encodes two of each protein class (aconitases AcnA and AcnB and ICDs Icd and
Idh). We found AcnA to be signiﬁcantly downregulated and AcnB to be signiﬁcantly
upregulated in the later stages of treatment. Similarly, expression of Icd, the monomeric
ICD, was unchanged, while the dimeric Idh was the protein most upregulated at the
14.5-h time point (40-fold more abundant than in the untreated control).
DISCUSSION
Here, we introduced an adaptation of BONCAT for selective, time-resolved pro-
teomic analyses of phenotypically distinct subpopulations of cells in genotypically
uniform bacterial cultures. As an example, we showed that this method reveals distinct
patterns of protein synthesis by antibiotic-tolerant bioﬁlm cells following extended
incubation with supra-MIC levels of ciproﬂoxacin. While the data reported here provide
guidance and motivation for future mechanistic studies, the most important result of
this work is the illustration of the power of BONCAT to resolve proteome dynamics in
space and time in phenotypically heterogeneous microbial systems. This method has
the potential to advance a variety of studies in the bioﬁlm ﬁeld.
Our observations provide evidence for both passive and active tolerance mecha-
nisms in bioﬁlms. A critical factor known to inﬂuence bacterial tolerance to antibiotics
is metabolic rate; cells with lowered rates of transcription, translation, and cell division
can survive inhibition of these processes, which are essential for growing cells (48, 49).
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Prior to antibiotic exposure, cells in the bioﬁlm interior had lower rates of ribosomal
protein synthesis and higher levels of the stationary-phase stress protein Dps, suggest-
ing that the region targeted by the rpoS promoter is populated by cells with stationary-
phase-like physiology and decreased metabolic rates. Ciproﬂoxacin exposure led to
reduced ribosome synthesis and downregulation of the cell division protein FtsZ,
indicating a shift by tolerant cells away from growth. Concurrent with the decrease in
ribosome synthesis, proteins important for responding to and repairing DNA damage
caused by ciproﬂoxacin (e.g., the SOS response) were upregulated. This analysis sug-
gested a coordinated shift away from active growth and toward surveillance and repair
of the effects of the stresses caused by treatment.
Although ribosome synthesis decreased, translation continued in tolerant cells, even
following extended ciproﬂoxacin treatment. After 14.5 h of antibiotic treatment, total
Anl incorporation decreased less than 2-fold compared to the untreated control. Colony
counts of viable cells showed a 99.8% decrease in cell numbers by the end of the time
course, while our imaging data showed that, in the absence of antibiotic, substantially
more than 0.2% of PrpoS:nll-mc bioﬁlm cells expressed NLL-MetRS–mCherry and were
labeled by Anl. One explanation to resolve this apparent discrepancy is that not all cells
that are translationally active within treated bioﬁlms can be cultured following bioﬁlm
disruption. Cells that are viable but nonculturable (VBNC) are observed in diverse
bacterial systems and can be induced by nutrient starvation and oxygen limitation,
conditions characteristic of bioﬁlm interiors (50). For example, planktonic E. coli cultures
treated with supra-MIC levels of ciproﬂoxacin have been shown to maintain membrane
potential and protein synthetic activity, despite log decreases in culturable cells (51).
BONCAT, as applied here, cannot differentiate translation by culturable cells, VBNCs, or
dying cells, but we suspect that the number of surviving cells may be larger than that
measured by colony counting.
The adaptive response of the P. aeruginosa bioﬁlm subpopulation presented here
leads to interesting questions about the role of proteome remodeling in ciproﬂoxacin
tolerance. For example, upregulation of ﬂagellar proteins is a hallmark of bioﬁlm
dispersal that occurs as bioﬁlms age (52) or in response to nutrient shifts (53). The
dispersal response is characterized by upregulation of the ﬂagellar ﬁlament FliC, which
we found to be upregulated immediately in response to ciproﬂoxacin challenge. We
also found large changes in the abundance of proteins with roles in central carbon
metabolism. In this category, we found differential expression of enzymes with similar
catalytic functions, i.e., the ICDs Idh (upregulated) and Icd (unchanged) and the
aconitases AcnA (downregulated) and AcnB (upregulated). To our knowledge, broad
adjustments to central carbon metabolism in P. aeruginosa bioﬁlms have not been
reported as a mechanism for ciproﬂoxacin tolerance. A recent study, however, identi-
ﬁed the TCA metabolites fumarate and glyoxylate as key modulators of P. aeruginosa
susceptibility to the aminoglycoside tobramycin (54). Does the early upregulation of
ﬂagellar proteins promote mobilization of bioﬁlm cells? How do the changes to the
central carbon proteome affect the intracellular redox balance and intermediate me-
tabolite concentrations? What is the physiological beneﬁt of the differential expression
of functionally redundant enzymes like the aconitases and ICDs? Dissecting the roles of
these proteins and others in the data set through focused genetic experiments and
metabolomics will lead to better understanding of these phenomena.
Study of the role of heterogeneity in bacterial physiology is hindered by the
difﬁculties of separating cell types of interest from their phenotypically distinct neigh-
bors. Because cell-selective BONCAT can be targeted using genetic regulatory ele-
ments, in principle the method is applicable to any genetically tractable organism. This
work describes methods for validating selective NLL-MetRS expression via a ﬂuorescent
protein fusion, validating selective Anl incorporation via ﬁxed cell imaging and SDS-
PAGE analysis, and for enriching and identifying proteins synthesized by a small
subpopulation of targeted cells. The BONCAT approach is readily adaptable to other
organisms and we expect these methods will be useful for the analysis of other
heterogeneous systems (e.g., planktonic persister cells or in vivo infections).
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MATERIALS AND METHODS
Strain construction. All strains used are listed in Table S3 and were generated using standard
cloning procedures. Enzymes were purchased from New England BioLabs. For chromosomal integration
into the Tn7 site, pUC18T mini-Tn7T was modiﬁed with the desired expression cassette, followed by
tetraparental conjugation to the PA14 host strain as previously described (55). Genomic DNA was
prepared using the GenElute bacterial DNA kit (Sigma-Aldrich). The 1-kb regions upstream of rpoS and
algP were ampliﬁed from P. aeruginosa genomic DNA. GFP-expressing cassettes contained the gene for
gfpmut3b cloned from pBK-mini-Tn7-gfp2 (56). The gene encoding the E. coli mutant methionyl-tRNA
synthetase was cloned from plasmid pJTN1 (29). A shuttle vector encoding arabinose-inducible expres-
sion of NLL-MetRS was created by cloning the gene from pJTN1 into pBAD18 (57) and then ligating the
fragment containing araC and Para:nll into pUCP24 (58) to generate pBADP-NLL. P. aeruginosa was
transformed by electroporation.
Media and growth conditions. Planktonic cultures were grown at 37°C with shaking. Liquid media
were LB (5 g yeast extract, 10 g tryptone, 10 g NaCl per liter), or FAB [2 g (NH4)2SO4, 6 g Na2HPO4 · 2H2O,
3 g KH2PO4, 3 g NaCl per liter] with 0.1 mM CaCl2, 1 mM MgCl2, and 1 ml/liter trace metals mix
(200 mg/liter CaSO4 · 2H2O, 200 mg/liter FeSO4 · 7H2O, 20 mg/liter MnSO4 · H2O, 20 mg/liter CuSO4 · 5H2O,
20 mg/liter ZnSO4 · 7H2O, 10 mg/liter CoSO4 · 7H2O, 12 mg/liter NaMoO4 · H2O, and 5 mg/liter H3BO3).
Carbon was supplied to FAB by addition of 0.05 g/liter glucose (for bioﬁlms) or 5 g/liter glucose (for
planktonic cultures) (59). For confocal imaging, bioﬁlms were grown in ﬂow cells (1 by 4 by 40 mm;
Stovall) as previously described (60), but without bubble traps. Bioﬁlms were grown at 37°C with a
constant ﬂow rate of 0.03 ml/min. For proteomic analyses, bioﬁlms were grown in silicone rubber tubing
(10-mm interior diameter, 20 cm long; McMaster-Carr) at 37°C with a constant ﬂow rate of 0.5 ml/min,
as previously described (61). Loosely adherent bioﬁlm cells were extracted by collecting media within
each tube and ﬂushing with 0.9% NaCl. Tubing was cut into 1-cm pieces and vortexed in 0.9% NaCl to
remove remaining cells. All cells were combined. To count viable cells, cells were washed once with
phosphate-buffered saline (PBS) and serial dilutions were made from each sample, spotted onto LB agar,
and allowed to grow for 16 h at 37°C.
BONCAT labeling and enrichment. For planktonic cell labeling experiments, strains from overnight
cultures were diluted 1:100 into FAB medium with 5 g/liter glucose. At each time point, labeling was
initiated by the addition of 1 mM Anl (Iris-Biotech). The strain containing pBADP-NLL-MetRS was grown
in the presence of 50 g/ml gentamicin and treated with 1 mM Anl and 20 mM arabinose. For all, after
15 min of incubation with Anl at 37°C with shaking, cells were pelleted at 4°C, washed once with ice-cold
0.9% NaCl, and frozen at80°C. For bioﬁlm experiments, ﬂow was stopped and tubing was clamped. FAB
medium with 0.05 g/liter glucose and 1 mM Anl was injected by syringe, and bioﬁlms were incubated
for 1.5 h at 37°C. For ciproﬂoxacin-treated samples, 60 g/ml ciproﬂoxacin was included in the labeling
medium. For proteomic analysis, cells were collected from tubing as described above, pelleted, and
frozen at 80°C.
All samples were lysed by resuspension in lysis buffer (100 mM Tris-HCl [pH 8], 4% SDS). Lysates were
sonicated with a microtip probe for 30 s at a setting of 20% (Qsonica). For Western blot detection of
NLL-MetRS, 10 g of each lysate was separated by SDS-PAGE, transferred to nitrocellulose (GE Health-
care), and probed with penta-His Alexa Fluor 488 (Qiagen). For ﬂuorescence detection of Anl-labeled
proteins, lysates were incubated with 5 M alkyne-TAMRA (Click Chemistry Tools), 100 M CuSO4,
500 M Tris(3-hydroxypropyltriazolylmethyl)amine (THPTA; Click Chemistry Tools), 5 mM aminoguani-
dine hydrochloride, and 5 mM sodium ascorbate for 15 min at room temperature (62). The mixtures were
then precipitated with water, methanol, and chloroform and washed twice with methanol. TAMRA-
labeled lysates were separated via SDS-PAGE (NuPAGE Novex 4-to-12% bis-Tris gels; Thermo Fisher
Scientiﬁc) and imaged on a Typhoon gel imager (GE Healthcare). Gels were stained with colloidal blue
(Life Technologies, Inc.) or Instant-Blue (Expedeon) Coomassie stains to verify equal protein loading.
For all enrichments, cysteines were reduced by addition of 10 mM dithiothreitol (DTT) for 20 min at
room temperature, and free thiols were alkylated by addition of 100 mM chloroacetamide for 30 min in
the dark. For the comparison between PrpoS:nll-mc and Ptrc:nll-mc bioﬁlms, 0.5 mg of protein lysate per
sample was treated with 12 M DBCO–sulfo-biotin (Click Chemistry Tools) in 0.5 ml PBS (137 mM NaCl,
2.7 mM KCl, 10 mM Na2HPO4, 1.8 mM KH2PO4) for 15 min at room temperature. Proteins were
precipitated with acetone at 20°C and resuspended in PBS, 0.3% SDS. A small sample (~20 g) of each
treated lysate was separated by SDS-PAGE, transferred to nitrocellulose, and probed for biotin conju-
gation with streptavidin-Alexa Fluor 488 (Thermo Fisher Scientiﬁc). The streptavidin UltraLink resin
(Pierce Biotechnology) was washed twice with PBS and added to biotinylated lysates, and this mixture
was incubated overnight at 4°C. Resin was transferred to microcentrifuge spin columns (Pierce Biotech-
nology) and washed twice with 1% SDS in PBS and once with 0.1% SDS in PBS. Proteins were eluted by
incubation with 1 mM biotin at 65°C for 20 min. Eluted proteins were separated via SDS-PAGE and
subjected to in-gel digestion coupled with LC-MS (GeLCMS).
For the comparison between ciproﬂoxacin-treated samples, lysates were reduced and alkylated as
described above. For each sample, approximately 0.5 mg of protein in 0.5 ml of PBS was incubated with
50 l of a DBCO-agarose bead 50% slurry (Click Chemistry Tools) for 2.5 h at room temperature. Beads
were washed extensively in gravity ﬂow columns (Bio-Rad) with 40 ml (8 volumes of 5 ml) each of (i) PBS,
0.8% (wt/vol) SDS; (ii) 8 M urea; and (iii) 20% (vol/vol) acetonitrile (ACN) in water. Beads were resus-
pended in 50 mM ammonium bicarbonate (AB) for on-bead tryptic digestion (see the LC-MS/MS section
for details).
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Imaging of planktonic cells. For imaging of planktonic cells, cell cultures were pelleted, washed in
PBS once, and resuspended in PBS. Cell suspensions were placed on 4% agarose pads, covered with a
coverslip, and imaged immediately.
Imaging of ﬂow cell bioﬁlms. For the ﬂow cell bioﬁlms, all treatments were applied via syringe. For
GFP imaging, ﬂow was stopped and live bioﬁlms were incubated with 0.05 M SYTO 62 (Thermo Fisher
Scientiﬁc) for 30 min at 37°C. For mCherry imaging, ﬂow was stopped and live bioﬁlms were incubated
with 0.05 M SYTO 9 (Thermo Fisher Scientiﬁc) for 30 min at 37°C. To visualize Anl incorporation, bioﬁlms
were ﬁxed by incubation with 3.7% formaldehyde for 30 min and permeabilized by incubation with 70%
ethanol for 5 min on ice. Fixed bioﬁlms were washed with 0.9% NaCl, incubated with 100 mM
chloroacetamide in the dark for 30 min, and treated with 25 M DBCO-TAMRA in PBS for 30 min. Bioﬁlms
were washed extensively with PBS to remove excess dye and counterstained with 0.05 M STYO 9.
Bioﬁlms were imaged on a Leica TCS SPE confocal microscope with a 40 or 63 objective.
LC-MS/MS. For GeLCMS, gel lanes were cut into 8 pieces each and destained by alternating washes
with 50 l each of 50 mM AB and a 1:1 mixture of 50 mM AB–ACN. Proteins were reduced by incubation
with 6.7 mM DTT in 50 l 50 mM AB at 50°C for 30 min and alkylated by incubation with 37 mM
iodoacetamide in 50 l 50 mM AB at room temperature for 20 min. Gel pieces were washed with 50 l
each of 100 mM AB and acetonitrile. Proteins were digested ﬁrst by addition of 300 ng endoproteinase
LysC in 50 l of 100 mM Tris-HCl at 37°C for 4 h and then by addition of 150 ng of trypsin for 16 h at
37°C. Peptides were extracted by sequential washing with 50 l each of 1% formic acid–2% acetonitrile,
1:1 acetonitrile-water, and 1% formic acid in acetonitrile. Peptides were desalted using C18 ZipTips (EMD
Millipore).
For on-bead digestion following BONCAT enrichment with DBCO-agarose, beads were incubated
with 100 ng trypsin in 100 l 9:1 50 mM AB:acetonitrile for 18 h at 37°C. Supernatant was collected and
beads were washed twice with 100 l 20% ACN to extract all peptides. Peptides were dried, passed
through HiPPR spin columns (Thermo Fisher Scientiﬁc) to remove residual SDS, and desalted with C18
ZipTips.
Liquid chromatography-mass spectrometry experiments were carried out essentially as previously
described (63). The rpoS versus trc experiments were performed on a nanoﬂow LC system, the EASY-nLC
1000, coupled to a hybrid linear ion trap Orbitrap classic mass spectrometer (Thermo Fisher Scientiﬁc)
equipped with a nanoelectrospray ion source (Thermo Fisher Scientiﬁc) with the following modiﬁcations:
for the EASY-nLC 1000 system, solvent A consisted of 97.8% H2O, 2% ACN, and 0.2% formic acid, and
solvent B consisted of 19.8% H2O, 80% ACN, and 0.2% formic acid. For the LC-MS/MS experiments,
digested peptides were directly loaded at a ﬂow rate of 500 nl/min onto a 16-cm analytical high-
performange LC (HPLC) column (75 m inner diameter) packed in-house with Reprosil-Pur C18AQ 3-m
resin (120 Å pore size; Maisch, Ammerbuch, Germany). The column was enclosed in a column heater
operating at 45°C. After a 30-min loading time, the peptides were separated in a solvent gradient at a
ﬂow rate of 350 nl/min. The gradient was as follows: 0 to 30% B (50 min) and then 100% B (10 min). The
Orbitrap was operated in data-dependent acquisition mode to automatically alternate between a full
scan (m/z 400 to 1,600) in the Orbitrap and a subsequent 10 collision-induced dissociation (CID) MS/MS
scans (the top 15 method) in the linear ion trap. CID was performed with helium as the collision gas at
a normalized collision energy of 35% and 30 ms of activation time. Ciproﬂoxacin experiments were
performed on a hybrid ion trap-Orbitrap Elite mass spectrometer (Thermo Fisher Scientiﬁc) with the same
acquisition method, except the top 20 ions were selected for fragmentation. The analytical column for
this instrument was a PicoFrit column (New Objective, Woburn, MA) packed in-house with Reprosil-Pur
C18AQ 1.9-m resin (120 Å pore size; Maisch, Ammerbuch, Germany), and the column was heated to
60°C. The peptides were separated with a 120-min gradient (0 to 30% B in 120 min) at a ﬂow rate of
220 nl/min.
Proteomic data analysis. Raw ﬁles were searched using MaxQuant (64) against the P. aeruginosa
PA14 UniProt entries (5,886 sequences) and a contaminant database (246 sequences). Trypsin was
speciﬁed as the digestion enzyme, with up to two missed cleavages. Carbamidomethylation of cysteine
was set as a ﬁxed modiﬁcation, and protein N-terminal acetylation and methionine oxidation were
variable modiﬁcations. Protein abundances were estimated with MaxLFQ (65), and for each experiment
peptides were matched between runs. LFQ values were normalized and used to calculate abundance
ratios between samples and to estimate variance using the limma package in R version 3.2.2 (66). P values
were adjusted for false discovery by using the Benjamini-Hochberg procedure (67).
Spearman’s rank correlations were calculated between experimental replicates by using raw LFQ
values. Principal-component analysis was performed on log10-transformed LFQ values and included only
proteins that were identiﬁed in all 12 MS analyses (n  291).
Software used for our analyses. Additional software packages that we used but that were not
mentioned above included the following. Data processing and statistical analysis were performed with
Python version 2.7.9 with NumPy version 1.9.2, SciPy version 0.15.1, Pandas version 0.16.1, and scikit-
learn version 0.17. Data were plotted with Matplotlib version 1.5.1 (68) and Seaborn version 0.8.0.
Microscopy and gel images were analyzed with ImageJ 64-bit version 2.0.0 (69). Figures were assembled
in Adobe Illustrator CS5.
Availability of data. The mass spectrometry proteomics data have been deposited with the
ProteomeXchange Consortium via the PRIDE (70) partner repository and assigned the data set identiﬁers
PXD007622 and PXD007261.
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SUPPLEMENTAL MATERIAL
Supplemental material for this article may be found at https://doi.org/10.1128/mBio
.01593-17.
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